Gene Therapy for Parkinson's Disease: Current Status and Future Potential

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.2, Iss.2, 2002-01, pp. : 135-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy in Parkinson's Disease: Rationale and Current Status

By > Maguire-Zeiss Kathleen A.

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 177-192

Adis International

Access to resources Recommend Favorite

Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives

Current Gene Therapy, Vol. 14, Iss. 6, 2014-12 ,pp. : 447-460

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy in Cardiovascular Disease: Current Status

By Francis S.C.

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 55-66

Adis International

Access to resources Recommend Favorite

GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 703-711

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory and Immune Therapy for Alzheimer's Disease: Current Status and Future Directions

Current Neuropharmacology, Vol. 5, Iss. 4, 2007-12 ,pp. : 232-243

Bentham Science Publishers

Access to resources Recommend Favorite